Navigation Links
SpermCheck® Fertility, the Only FDA Approved At-Home Screening Test for Men to Determine Normal or Low Sperm Count, Now Available to Couples Planning or Struggling to Conceive

CHARLOTTESVILLE, Va., Feb. 21, 2012 /PRNewswire/ -- This year, approximately 7 million couples will experience conception issues. A key first step, before the female goes through a battery of tests, is to analyze the male's sperm count, yet it is estimated that only 20% of men in couples struggling to conceive have this test early on or at all.  Enter SpermCheck® Fertility (, the only FDA approved at-home screening test for men to determine normal or low sperm count with 98% accuracy, in 10 minutes and without having to go to a physician or lab to provide a semen sample. 

"SpermCheck Fertility is non-invasive and can help couples eliminate or identify one potential stumbling block to conception," explains Ray Lopez, CEO of SpermCheck®, which also manufacturers a home test for post-vasectomy screening.

"Men have historically avoided this type of semen analysis because it can be embarrassing and inconvenient for them to go to a physician or lab for this type of test, yet approximately 50% of all infertility problems are directly attributed to the male, and most of them are mainly due to low sperm count," explains Lopez. "With such high incidence of fertility issues, coupled with low incidence of male testing, we saw a great opportunity to provide couples with an at-home test that can provide information that is crucial for conception preparation, yet takes the stigma out of the test, since it is done in the privacy of their own home." 

In just 10 minutes, SpermCheck® Fertility indicates if sperm count is within "normal" range (at or above 20 million sperm per milliliter, which is the accepted standard for normal sperm count) or low, which would indicate that a visit to the physician for further analysis of the man is in order.

"It's more than 98% accurate – as reliable as a lab test – yet much more convenient and at much less cost than a visit to the doctor," adds Lopez.  "It also alleviates the embarrassment and inconvenience of providing a semen sample to a doctor or nurse in a lab setting."

The test was developed by Dr. John Herr, Ph.D., director of the Center of Cell Biology at the University of Virginia, based on a process made possible by a protein, found exclusively in the head of mature sperm, discovered 21 years ago. Dr. Herr remains involved with SpermCheck as the Chief Scientific Officer and Chairman.

"This at-home test was created to meet the needs of couples who are considering and just planning on starting a family, those currently having trouble conceiving and even those men who are just curious about their sperm count," adds Dr. Herr. 

To help support the SpermCheck® Fertility launch, the company is embarking on a digital ad and social media strategy to connect directly with consumers and influencers where they are searching and conversing about this topic.

SpermCheck® Fertility is currently available online at and, and will be available in stores nationwide in April 2012. Suggested retail price is $39.99. For more information about SpermCheck® Fertility, visit

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Pamela Madsen

SOURCE SpermCheck®
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
2. Radient Pharmaceuticals Announces Proxy Resolutions Approved at Special Meeting of Stockholders
3. BYETTA® Approved for Use with Insulin Glargine in the U.S.
4. Life Technologies Introduces First and Only USDA-Approved Real-Time PCR Test to Detect Swine Influenza Virus
5. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
6. Intrinsic Bioprobes Launches Three New CLIA Approved Mass Spectrometry-Based Tests for Proteins Implicated in Kidney Disease and Renal Failure
7. Tissue Genesis Begins FDA-Approved Clinical Trial
8. Calipers Microfluidic Technologies Enable 510(k) Approved Multiplexed Immunoassay System for Liver Cancer Risk Assessment
9. Arkion Bird Repellent Approved for Use in Three Southern States
10. Shionogi Announces FDA Approval of KAPVAY™ - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD
11. Helix BioPharma Approved for NYSE Amex Listing
Post Your Comments:
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 2016 Andrew D ... Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
Breaking Biology News(10 mins):